# Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

> **NCT01792713** · PHASE2 · COMPLETED · sponsor: **Spirig Pharma Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Skin Alterations Associated With Atopic Dermatitis

## Interventions

- **DRUG:** Sertaconazole 2% cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01792713
- **Lead sponsor:** Spirig Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-09
- **Final completion:** 2014-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792713, "Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01792713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*